Matches in Wikidata for { <http://www.wikidata.org/entity/Q97553876> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q97553876 description "2020 թվականի հուլիսի 11-ին հրատարակված գիտական հոդված" @default.
- Q97553876 description "artículu científicu espublizáu en xunetu de 2020" @default.
- Q97553876 description "scientific article published on 11 July 2020" @default.
- Q97553876 description "wetenschappelijk artikel" @default.
- Q97553876 description "наукова стаття, опублікована 11 липня 2020" @default.
- Q97553876 name "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 name "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 type Item @default.
- Q97553876 label "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 label "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 prefLabel "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 prefLabel "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 P1433 Q97553876-1F33E10A-AF2C-4242-892C-58C791FA9C81 @default.
- Q97553876 P1476 Q97553876-842DDE67-B636-4944-956D-20D0BC5DD2D1 @default.
- Q97553876 P2093 Q97553876-17887F6B-BCD4-4048-BF45-B951E385F02E @default.
- Q97553876 P2093 Q97553876-2C92C6E0-086A-4B28-B7F7-5F249EE39457 @default.
- Q97553876 P2093 Q97553876-421AFBC4-95CF-4C4E-96E6-67089FDBCBFE @default.
- Q97553876 P2093 Q97553876-648EB070-4475-44D8-9A90-8062DF6904D0 @default.
- Q97553876 P2093 Q97553876-65A84DF6-4702-43F7-AABC-BABF2AA3D1C3 @default.
- Q97553876 P2093 Q97553876-96AC8B7B-6FB2-4DAF-99E2-90553E43DE65 @default.
- Q97553876 P2093 Q97553876-C329BC3B-8EFE-4DE1-8125-F227DD653ABF @default.
- Q97553876 P2093 Q97553876-F267AB7E-FB88-4570-A1C7-825E7B1103EE @default.
- Q97553876 P304 Q97553876-A877F2BE-C38C-4D1B-8E54-D6029B216F8A @default.
- Q97553876 P31 Q97553876-7D86E8D4-31F7-433D-A8A0-24F26660EBDB @default.
- Q97553876 P356 Q97553876-E352628E-2042-4AE4-9D93-F4F840999969 @default.
- Q97553876 P50 Q97553876-0A17284A-5211-4820-A5E1-86C2A7FD2031 @default.
- Q97553876 P50 Q97553876-6E29455B-5D16-4275-878B-A01736DDFF28 @default.
- Q97553876 P577 Q97553876-B45217FE-A261-45ED-81AC-CEC8EFC637FB @default.
- Q97553876 P698 Q97553876-CA3D29D2-C707-460F-A999-767DBD41998F @default.
- Q97553876 P921 Q97553876-0F67629C-A881-4280-9923-DA45A34D0B9B @default.
- Q97553876 P932 Q97553876-DC4337A9-DF9C-452E-85AD-9DD80231E543 @default.
- Q97553876 P356 J.IJPHARM.2020.119623 @default.
- Q97553876 P698 32663582 @default.
- Q97553876 P1433 Q6051539 @default.
- Q97553876 P1476 "Trans-urocanic acid enhances tenofovir alafenamide stability for long-acting HIV applications" @default.
- Q97553876 P2093 "Alessandro Grattoni" @default.
- Q97553876 P2093 "Antons Sizovs" @default.
- Q97553876 P2093 "Corrine Ying Xuan Chua" @default.
- Q97553876 P2093 "Fernanda P Pons-Faudoa" @default.
- Q97553876 P2093 "Gulsah Malgir" @default.
- Q97553876 P2093 "Kathryn A Shelton" @default.
- Q97553876 P2093 "Lane R Bushman" @default.
- Q97553876 P2093 "Peter L Anderson" @default.
- Q97553876 P304 "119623" @default.
- Q97553876 P31 Q13442814 @default.
- Q97553876 P356 "10.1016/J.IJPHARM.2020.119623" @default.
- Q97553876 P50 Q58305544 @default.
- Q97553876 P50 Q59691087 @default.
- Q97553876 P577 "2020-07-11T00:00:00Z" @default.
- Q97553876 P698 "32663582" @default.
- Q97553876 P921 Q155954 @default.
- Q97553876 P932 "7484042" @default.